Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar squiggley64 (93.84) Submitted: 2/1/2008 11:40:21 AM : Outperform Start Price: $6.81 SLXP Score: +647.55

All in the tract

Featured Broker Partners


Advertisement